Insurance companies increase prices for expensive drugs
People with multiple sclerosis, rheumatoid arthritis, hepatitis, and some forms of cancer are having to pay a much greater share of the cost of their medications, due to a change in many insurance plans. Patients now have to pay 20 to 33 percent of the drug's cost instead of a flat co-pay. This trend started with Medicare drug coverage plans and is now spreading to private insurance plans.
(New York Times) UPDATED 04/14/2008Click here to read the full story

